市場調查報告書
商品編碼
1466184
腦脊髓液 (CSF) 管理市場:全球規模、佔有率、趨勢分析、機會、預測報告,2019-2030Cerebrospinal Fluid Management Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product; By End User; By Region |
到 2030 年,全球腦脊髓液 (CSF) 管理市場規模將增加一倍以上,達到 30 億美元
由於水腦症和其他神經系統疾病的負擔日益增加,以及老年人口的不斷成長,全球腦脊髓液(CSF)管理市場正在蓬勃發展。
領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中估計,2023 年全球腦脊髓液 (CSF) 管理市場規模為 13.7 億美元。 BlueWeave 預測,在 2024-2030 年預測期內,全球腦脊髓液 (CSF) 管理市場規模將以 5.12% 的年複合成長率成長,到 2030 年達到 29.8 億美元。腦脊髓液相關疾病(如腦膜炎、蜘蛛膜下腔出血和水腦症)發生率的上升是推動全球腦脊髓液(CSF)管理市場的關鍵因素之一。此外,在分析期間,全球腦脊髓液(CSF)管理市場預計將受到老年人口增加以及帕金森氏症和阿茲海默症疾病發病率增加的推動。
機會:新興國家加大對醫療保健的投資
包括印度、巴西在內的主要新興國家由於活性化,正在活性化投資醫療領域,以加強本國的醫療基礎設施。開發中國家和低收入國家水腦症的高盛行率主要是由於社會經濟地位低和缺乏葉酸補充所造成的。因此,對腦脊髓液(CSF)管理的需求預計將增加並推動整個市場。
地緣政治緊張局勢加劇對全球腦脊髓液(CSF)管理市場的影響
地緣政治緊張局勢的加劇對全球腦脊髓液(CSF)管理市場的成長產生負面影響。戰爭、衝突和種族滅絕等情況影響患者獲得適當的醫療保健服務,並導致醫療用品短缺。例如,俄羅斯和以色列分別摧毀了烏克蘭和巴勒斯坦的幾家醫院,導致整個醫療系統崩壞,許多醫護人員流散。許多面臨地緣政治緊張局勢的其他國家獲得腦脊髓液(CSF)管理醫療用品的資源有限,這限制了全球市場的成長。
全球腦脊髓液 (CSF) 管理市場
按細分市場分類的覆蓋範圍
全球腦脊髓液 (CSF) 管理市場 – 依最終用戶分類
根據最終用戶,全球腦脊髓液(CSF)管理市場分為兒童、成人和老年。由於兒童先天性水腦症的盛行率不斷上升,兒童市場佔有最高的市場佔有率。先天性水腦症是指從出生起腦中就有過多的腦脊髓液 (CSF)。因此,兒童分流手術的數量也在快速成長,推動了全球腦脊髓液(CSF)管理市場的發展。
全球腦脊髓液 (CSF) 管理市場 - 按地區
該研究報告對全球腦脊髓液(CSF)管理市場進行了深入研究,包括五個主要地區的眾多各國市場:北美、歐洲、亞太地區(APAC)、拉丁美洲、中東非洲。北美主導全球腦脊髓液(CSF)管理市場。該地區在市場上的主導地位主要是由於老年人口的成長和神經病變的流行。此外,該領域的廣泛研發活動以及美國FDA 對新產品的核准預計將為預測期內腦脊髓液 (CSF) 管理市場的主要參與者提供有利的成長機會。
競爭格局
全球腦脊髓液 (CSF) 管理市場的主要企業包括 Medtronic Plc、B. Braun Melsungen AG、Integra Lifesciences、Natus Medical Incorporated、Sophysa、Aesculap AG、Spiegelberg GmbH &Co.KG、Moeller Medica、IRRAS AB、Argi Group、索菲薩。
這些公司正在採取各種策略,例如併購、合作、合資、授權合約和新產品推出,以進一步增加其市場佔有率。
該報告的詳細分析提供了有關成長潛力、未來趨勢和全球腦脊髓液(CSF)管理市場的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於提供全球腦脊髓液(CSF)管理市場的最新技術趨勢以及產業見解,以幫助決策者做出適當的策略決策。此外,我們也分析了市場的成長動力、挑戰和競爭力。
Global Cerebrospinal Fluid (CSF) Management Market Size Set to More Than Double Touching USD 3 Billion by 2030
Global Cerebrospinal Fluid (CSF) Management Market is flourishing because of the increasing burden of hydrocephalus and other neurological disorders and growing geriatric population.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Cerebrospinal Fluid (CSF) Management Market size at USD 1.37 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cerebrospinal Fluid (CSF) Management Market size to expand at a CAGR of 5.12% reaching a value of USD 2.98 billion by 2030. The rising incidence of illnesses linked to CSF, such as meningitis, subarachnoid hemorrhage, and hydrocephalus, is one of the main driving reasons for the Global Cerebrospinal Fluid (CSF) Management Market. Furthermore, it is projected that the Global Cerebrospinal Fluid (CSF) Management Market will be driven by a growing elderly population and the increasing incidence of illnesses like Parkinson's and Alzheimer's during the period in analysis.
Opportunity: Growing investments in healthcare sector by developing countries
Major emerging economies, including India and Brazil, have been significantly investing in their healthcare sector to strengthen the healthcare infrastructure across their countries owing to an increasing patient pool and to boost medical tourism in their respective countries. The high prevalence of hydrocephalus in developing and lower-income countries is mainly attributed to low socioeconomic status and a lack of folic acid supplementation. As a result, the demand for cerebrospinal fluid (CSF) management is projected to grow, driving the overall market.
Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market
The escalating geopolitical tensions negatively impact the growth of the Global Cerebrospinal Fluid (CSF) Management Market. Situations like war, conflicts, and genocide impact the patient's accessibility to proper healthcare services and result in a shortage of medical supplies. Russia and Israel, for instance, destroyed several hospitals in Ukraine and Palestine, respectively, which resulted in the breakdown of the entire healthcare system and the displacement of many healthcare workers. Many other countries that are facing geopolitical tensions have limited resources to acquire medical supplies for performing cerebrospinal fluid (CSF) management, which limits its global market growth.
Global Cerebrospinal Fluid (CSF) Management Market
Segmental Coverage
Global Cerebrospinal Fluid (CSF) Management Market - By End User
Based on the end user, the Global Cerebrospinal Fluid (CSF) Management Market is segmented into pediatric, adult, and geriatric. The pediatric segment accounts for the highest market share owing to the increasing prevalence of congenital hydrocephalus among children. Overabundance of cerebrospinal fluid (CSF) in the brain from birth results in congenital hydrocephalus. As a result, the number of shunt procedures performed on children is also rising at a high rate, driving the global cerebrospinal fluid (CSF) management market.
Global Cerebrospinal Fluid (CSF) Management Market - By Region
The in-depth research report on the Global Cerebrospinal Fluid (CSF) Management Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Cerebrospinal Fluid (CSF) Management Market. The region's dominance in the market is mainly attributed to the growing elderly population and the prevalence of nervous disorders. Furthermore, extensive research and development activities in this field and approvals of new products by the US FDA are anticipated to present lucrative growth opportunities to the major players in the Cerebrospinal Fluid (CSF) Management Market over the forecast period.
Competitive Landscape
Major players operating in the Global Cerebrospinal Fluid (CSF) Management Market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences, Natus Medical Incorporated, Sophysa, Aesculap AG, Spiegelberg GmbH & Co. KG, Moeller Medica, IRRAS AB, Argi Group, and Sophysa.
These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Cerebrospinal Fluid (CSF) Management Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Cerebrospinal Fluid (CSF) Management Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable